Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. A return to economic normalcy has largely been tied to the arrival of vaccines that can prevent infections from the coronavirus.
Have Watchlists? InvestorPlace We are updating this guide regularly with what we learn about the state of testing and treatment across the U.S.The Dow Jones Industrial Average surged on optimism that economic activity is gathering steam and authorities may offer more stimulus to bolster the recovery.Shares of economically sensitive companies like manufacturers, energy companies and banks are powering the latest leg of the stock market’s recovery.The central bank leaped to the rescue, eclipsing even positive Covid-19 vaccination data to give market bulls a lift. ET INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. "While the FDA is committed to help expedite this work, we will not cut corners in our decision making, and we're making clear in our guidance what are the data that we need, that should be submitted, to meet our regulatory standards of approval," FDA commissioner Dr. Stephen Hahn said Tuesday during a Senate committee hearing. Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. ET). To date, 16.7 million people have been infected ...Inovio rallies on encouraging preclinical results on COVID-19 vaccineIn a report released today, Ram Selvaraju from H.C.[...]Whatever Happens to Inovio Pharmaceuticals, Insiders Will Do Just FineAs Optimism Wanes, the Ride May Be Over for Novavax stockWhy Novavax Stock is Still a Strong Buy Even After an 800% MoveThe Further It Lags in the Vaccine Race, the Riskier Inovio Stock LooksYou Could Retire in Your 40s By Following the FIRE MovementHistory and Competition Suggest Caution Toward Inovio StockKamada: Under-The-Radar COVID-19 Therapy Play With Downside Protection And Margin Of SafetyGlobal Non-Invasive Drug Delivery Market 2020 Growth by Opportunities, Application, Current Trend and Forecast by 2025Global Intramuscular Drug Delivery Equipment Market 2020: Latest In-Depth Report Segment by Manufacturers, Type, Applications and DynamicsINOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 VirusKarl Fischer Titrators Market size 2020 Top Companies data engage in Introducing Improved Types of Products to Increase Sales, (New Report): Metrohm, Mettler Toledo, HACH LANGEThinking about trading options or stock in Advanced Micro Devices, Starbucks, Inovio Pharmaceuticals, Boeing, or Caesars Entertainment?INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)Zika Virus Market size 2020 Top Companies data engage in Introducing Improved Types of Products to Increase Sales, (New Report): Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, IntrexonResearchers Identify Potent Infection-Blocking Antibodies In Race For COVID-19 VaccineResearchers Identify Potent Infection-Blocking Antibodies In Race For COVID-19 VaccineBovine Respiratory Disease Treatment Market by Current Industry Status, Growth Opportunities, Top Key Players, Target Audience and Forecast To 2026INOVIO to Report Second Quarter 2020 Financial Results on August 10, 2020Non-Invasive Drug Delivery Device Market By Current Industry Status, Growth Opportunities, Top Key Players, Target Audience And Forecast To 2026Needle-Free Injection System Market Future Scope, Opportunities with Strategic Growth and Top PlayersNeedle-Free Injection System Market Analysis With Key Players, Applications, Trends and Forecast To 2026Prosthetic Joint Infections Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027HIV Therapeutic & Preventive Vaccines Market Trends Adopted by the Competitors, Regions with Forecast by 2022COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020 Global Trend, Segmentation and Opportunities, Forecast 2026Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market 2020 Industry Outlook, Classification, Demand, Regional Analysis and Forecast to 2025Global Intramuscular Drug Delivery Equipment Market 2020 Key Stakeholders, Growth Opportunities, Value Chain and Sales Channels Analysis 2025 The drug giant and its German biotech partner BioNTech said a small group of people who received relatively low doses developed more antibodies than people who had recovered from Covid-19.The Food and Drug Administration’s new guidance document for developers of Covid-19 vaccines doesn’t spell out a timeline. It also plans to start a Phase 2/3 study this summer. CNBC Analyst Activity ET) and the After Hours Market (4:00-8:00 p.m. Major indexes clawed back after Tuesday’s losses on optimism about the prospects for a global economic recovery. Data is currently not available. A 10% selloff in the stock market is most likely, says expert who called March lows: ‘Something has to give’
(Three trial participants tested positive for COVID-19 and one left the study for non-clinical reasons.) InvestorPlace Topics The company's stock hit a record high of $31.69 on Monday, the day before it released the positive, yet limited data about its vaccine candidate.
The S&P 500 is down 4.0% year-to-date.